JAYME PETERSON: Open Payments
NPI 1104659325 · NORTHGLENN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 109 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $378 · 2025 $2,185
Food & beverage: $2,185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $472 |
| AstraZeneca Pharmaceuticals LP | 18 | $345 |
| GlaxoSmithKline, LLC. | 14 | $288 |
| Janssen Pharmaceuticals, Inc | 3 | $170 |
| PFIZER INC. | 8 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $133 |
| Lilly USA, LLC | 6 | $96 |
| Novo Nordisk Inc | 5 | $96 |
| Amgen Inc. | 5 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
Products named: VRAYLAR, TRELEGY ELLIPTA, SPRAVATO, JARDIANCE, NURTEC ODT, Wegovy, MOUNJARO, FARXIGA.
Industry payments across CO — which companies pay providers there.
